$12.88
+0.09 (+0.70%)
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+389.2% upside
Low Target
$47.40
Average Target
$63.01
High Target
$83.78
Current Price
$12.88
Current
$12.88
$12.88
Target
$63.01
$63.01
$47.40
$63.01 avg
$83.78
Scenario Analysis
Bear Case
$47.40
268.0%
Low target
Base Case
$63.01
+389.2%
Avg target
Bull Case
$83.78
+550.5%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$15.35
-16.1% from high
52-Week Low
$6.62
+94.6% from low
Target vs 52W High
$63.01
+310.5% vs high
Next Earnings Report
Aug 12, 2026
3d
until earnings
EPS Est: $-0.34
Earnings in 3 days. Analyst targets may shift significantly after the report.
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 79% | $257.58 | +4.7% |
| AMGN | Hold | 43 | 49% | $190.87 | -53.6% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +172.3% |
| VRTX | Strong Buy | 40 | 83% | $438.34 | -11.6% |
| REGN | Buy | 38 | 71% | $76.80 | -90.2% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -55.6% |
| RVMD | Strong Buy | 29 | 93% | $114.11 | -44.4% |
| BIIB | Buy | 44 | 64% | $91.45 | -56.0% |